Excess health care costs of obesity in adults with diabetes mellitus: A claims data analysis

Experimental and Clinical Endocrinology and Diabetes

Volumn 118, Issue 8, 2010, Pages 496-504

  Von Lengerke, T ^a   Hagenmeyer, E G ^b   Gothe, H ^c   Schiffhorst, G ^b   Happich, M ^d   Hussler B ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b IGES GmbH   (Germany)

^c UNIVERSITY FOR HEALTH SCIENCES   (Austria)

^d LILLY DEUTSCHLAND GMBH   (Germany)

Author keywords

diabetes mellitus; health; health care costs; insurance; insurance claim review; obesity; reimbursement

Indexed keywords

ADULT; AGED; ARTICLE; COMORBIDITY; DISEASE ASSOCIATION; DRUG USE; FEMALE; GERMANY; HEALTH CARE COST; HEALTH INSURANCE; HOSPITAL PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTPATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; VASCULAR DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INSURANCE CLAIM REVIEW; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIDDLE AGED; OBESITY; YOUNG ADULT;

EID: 77956955438     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0030-1253400     Document Type: Article

References (52)

1. American Diabetes Association. Standards of medical care in diabetes 2007. Diabetes Care 2007 30 S4-S41
2. Ryden L, Standl E, Bartnik M, et al. Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD): Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. Eur Heart J 2007 28 88-136
3. Matthaei S, Bierwirth R, Fritsche A, et al. Behandlung des Diabetes mellitus Typ 2. In German. Diabetologie 2009 4 S138-S143
4. Wing RR, Goldstein MG, Acton KJ, et al. Behavioral science research in diabetes: lifestyle changes related to obesity, eating behavior, and physical activity. Diabetes Care 2001 24 117-123
5. Norris SL, Zhang X, Avenell A, et al. Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus. Cochrane Database Syst Rev 2005; (1): CD004096
6. Kennedy RL, Khoo EY. New options for drug treatment of obesity in patients with Type 2 diabetes. Diabet Med 2005 22 23-26
7. Barnett A, Allsworth J, Jameson K, et al. A review of the effects of antihyperglycaemic agents on body weight: the potential of incretin targeted therapies. Curr Med Res Opin 2007 23 1493-1507
8. Kendall DM, Riddle MC, Rosenstock J, et al. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea. Diabetes Care 2005 28 1083-1091
9. Viswanathan P, Chaudhuri A, Bhatia R, et al. Exenatide therapy in obese patients with type 2 diabetes mellitus treated with insulin. Endocr Pract 2007 13 444-450
10. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group. Modern-day clinical course of type 1 diabetes mellitus after 30 years duration: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications and Pittsburgh Epidemiology of Diabetes Complications Experience (1983-2005). Arch Intern Med 2009 169 1307-1316
11. Martin S, Dreyer M, Kiess W, et al. Behandlung des Diabetes mellitus Typ 1. In German. Diabetologie 2009 4 S136-S137
12. Conway B, Miller RG, Costacou T, et al. Adiposity and mortality in type 1 diabetes. Int J Obes 2009 33 796-805
13. Delahanty LM, Nathan DM, Lachin JM, et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications. Association of diet with glycated hemoglobin during intensive treatment of type 1 diabetes in the Diabetes Control and Complications Trial. Am J Clin Nutr 2009 89 518-524
14. The Diabetes Control and Complications Trial Research Group. Influence of intensive diabetes treatment on body weight and composition of adults with type 1 diabetes in the Diabetes Control and Complications Trial. Diabetes Care 2001 24 1711-1721
15. Williams KV, Erbey JR, Becker D, et al. Improved glycemic control reduces the impact of weight gain on cardiovascular risk factors in type 1 diabetes: The Epidemiology of Diabetes Complications Study. Diabetes Care 1999 22 1084-1091
16. Renders CM, Valk GD, Griffin S, et al. Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings. Cochrane Database Syst Rev 2000; (4) CD001481
17. Clark M. Is weight loss a realistic goal of treatment in type 2 diabetes? The implications of restraint theory. Patient Educ Couns 2004 53 277-283
18. Barnett A, Allsworth J, Jameson K, et al. A review of the effects of antihyperglycaemic agents on body weight: the potential of incretin targeted therapies. Curr Med Res Opin 2007 23 1493-1507
19. Liatis S, Thomakos P, Papaoikonomou S, et al. Trends in the management of type 2 diabetes and its prescription drug costs in Greece (1998 & 2006). Exp Clin Endocrinol Diabetes 2009 117 505-510
20. Stock SAK, Redaelli M, Wendland G, et al. Diabetes prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in Germany. Diabet Med 2005 23 299-305
21. Jönsson B. Revealing the cost of type II diabetes in Europe. Diabetologia 2002 45 S5-S12
22. Köster I, von Ferber L, Ihle P, et al. The cost burden of diabetes mellitus: the evidence from Germany the CoDiM Study. Diabetologia 2006 49 1498-1504
23. von Ferber L, Köster I, Hauner H. Medical costs of diabetic complications total costs and excess costs by age and type of treatment: results of the German CoDiM Study. Exp Clin Endocrinol Diabetes 2007 115 97-104
24. Gandra SR, Lawrence LW, Parasuraman BM, et al. Total and component health care costs in a non-medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease. J Manag Care Pharm 2006 12 546-554
25. Ettaro L, Songer TJ, Zhang P, et al. Cost-of-illness studies in diabetes mellitus. Pharmacoeconomics 2004 22 149-164
26. Finkelstein EA, Brown DS, Trogdon JG, et al. Age-specific impact of obesity on prevalence and costs of diabetes and dyslipidemia. Value Health 2007 10 S45-S51
27. Krauth C, Hessel F, Hansmeier T, et al. Empirical standard costs for health economic evaluation in Germany a proposal by the Working Group Methods in Health Economic Evaluation). In German. Gesundheitswesen 2005 67 736-746
28. Federal Statistical Office. Diagnosedaten der Patienten und Patientinnen in Krankenḧusern (einschl. Sterbe- und Stundenf̈lle) In German. Wiesbaden Federal Statistical Office 2005
29. Federal Ministry of Health and Social Security. Statistisches Taschenbuch 2004: Arbeits- und Sozialpolitik. In German. Bonn; Federal Ministry of Health and Social Security 2005
30. Federal Statistical Office. Statistisches Jahrbuch 2004. In German. Wiesbaden; Federal Statistical Office 2005
31. Federal Statistical Office. Diagnosedaten der Patienten und Patientinnen in Vorsorge- und Rehabilitationseinrichtungen 2004. In German. Wiesbaden; Federal Statistical Office 2006
32. Federal Statistical Office. Gesundheit: Ausgaben, Krankheitskosten und Personal 2004. Presseexemplar. In German. Wiesbaden; Federal Statistical Office 2006
33. Barber J, Thompson S. Multiple regression of cost data: use of generalised linear models. J Health Serv Res Policy 2004 9 197-204
34. Dodd S, Bassi A, Bodger K, et al. A comparison of multivariable regression models to analyse cost data. J Eval Clin Pract 2006 12 76-86
35. Manning WG. Modeling Costs with Generalized Gamma Regression.. http://www.spc.uchicago.edu/prc/pdfs/mannin02.pdf (last visited 8/28/2009)
36. Manning WG, Mullahy J. Estimating log models: to transform or not to transform? Journal of Health Economics 2001 20 461-494
37. Bramlage P, Wittchen HU, Pittrow D, et al. Recognition and management of overweight and obesity in primary care in Germany. Int J Obes Relat Metab Disord 2004 28 1299-1308
38. von Lengerke T, Reitmeir P, John J. Direct medical costs of (severe) obesity: a bottom-up assessment of over- vs. normal-weight adults in the KORA-Study Region (Augsburg, Germany)). In German. Gesundheitswesen 2006 68 110-115
39. Andreyeva T, Sturm R, Ringel JS. Moderate and severe obesity have large differences in health care costs. Obes Res 2004 68 1936-1943
40. Pyör̈l̈ K, Lehto S, De Bacquer D, et al. EUROASPIRE I and II Groups: Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I and II surveys. Diabetologia 2004 47 1257-1265
41. Rathmann W, Haastert B, Icks A, et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: Target populations for efficient screening. The KORA survey 2000. Diabetologia 2003 46 182-189
42. Klauber J, Robra B-P, Schellschmidt H. editors. Krankenhaus-Report 2007. Schwerpunkt: Krankenhausvergütung Ende der Konvergenzphase? In German Stuttgart; Schattauer 2008
43. von Lengerke T, John J, Mielck A, KORA Study Group. Excess direct medical costs of severe obesity by socioeconomic status in German adults. Psychosoc Med 2010 7 Doc01
44. Wittek A, Sokalski B, Grzeszczak W, et al. Prevalence of diabetes and cardiovascular risk factors of industrial area in southern Poland. Exp Clin Endocrinol Diabetes 2009 117 350-353
45. Li J, Bergmann A, Reimann M, et al. A more simplified Finnish diabetes risk score for opportunistic screening of undiagnosed type 2 diabetes in a German population with a family history of the metabolic syndrome. Horm Metab Res 2009 41 98-103
46. Schwarz PE, Lindström J, Kissimova-Scarbeck K, et al. DE-PLAN project. The European perspective of type 2 diabetes prevention: diabetes in Europe prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project. Exp Clin Endocrinol Diabetes 2008 116 167-172
47. Schwarz PE, Li J, Lindstrom J, et al. Tools for predicting the risk of type 2 diabetes in daily practice. Horm Metab Res 2009 41 86-97
48. Cawley J, Prinz T, Beane S, New York State Bariatric Surgery Workgroup. Health insurance claims data as a means of assessing reduction in co-morbidities 6 months after bariatric surgery. Obes Surg 2006 16 852-858
49. Happich M, Reitberger U, Breischeidel L, et al. The economic burden of diabetic retinopathy in Germany in 2002. Graefe's Arch Clin Exp Ophtahlmol 2008 246 151-159
50. Legato MJ, Gelzer A, Goland R, et al. Writing Group for The Partnership for Gender-Specific Medicine: Gender-specific care of the patient with diabetes: review and recommendations. Gend Med 2006 3 131-158
51. Wadén J, Tikkanen H, Forsblom C, etal FinnDiane Study Group. Leisure time physical activity is associated with poor glycemic control in type 1 diabetic women: the FinnDiane study. Diabetes Care 2005 28 777-782
52. Yu AP, Wu EQ, Birnbaum HG, et al. Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data. Curr Med Res Opin 2007 23 2157-2169